research Experimental and Early Investigational Drugs for Androgenetic Alopecia
New hair loss treatments may include topical medications, injections, and improved transplant methods.
Search
forLearn
0 / 0 results — no results
Research
5 / 243 results 
research Male Pattern Baldness: Causes, Treatments, and Future Prospects
Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.
research A Comprehensive Review on Deep Eutectic Solvents and Their Use to Extract Bioactive Compounds of Pharmaceutical Interest
Deep eutectic solvents are eco-friendly and effective for extracting useful pharmaceutical compounds.
research Cortexolone 17a-Propionate: Preclinical Profile of a New Topical, Skin Selective, Steroidal Antiandrogen
Clofazimine may be effective for treating ashy dermatosis.
research Ashy Dermatosis: Treatment with Clofazimine
Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.
Community Join
5 / 43 resultscommunity Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
by
hzah1
in Research/Science
35 upvotes
9 months ago Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.
community Binding affinity does not equal potency for anti androgens? Comparing pyrilutimide to cb-03-01
by
rhguven
in Research/Science
8 upvotes
2 years ago Pyrilutimide and CB-03-01, two treatments for hair loss, have similar clinical trial results despite different binding affinities to androgen receptors. Factors other than binding affinity, like the time a drug stays bound to the receptor, may influence their effectiveness.
community Breezula will hit the market in 2026, Cosmo Pharmaceuticals statement!
by
Particular_Hunter844
in Product
53 upvotes
10 months ago Breezula, a hair loss treatment, is expected to cost around $100 a month and is anticipated to be released in 2026. The effectiveness of Breezula is debated, with some suggesting it loses effectiveness over time and others arguing it maintains hair compared to baseline.
community I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.
by
noeyys
in Research/Science
152 upvotes
1 month ago GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.
community Brief update clascoterone phase 3 - Breezula
by Particular_Hunter844
in Research/Science
4 upvotes
10 months ago Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase 3 clinical trials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.